← Back to headlines
Argenx to Acquire Forte Biosciences for $2.2 Billion
Argenx has signed an agreement to acquire Forte Biosciences in a deal valued at $2.2 billion.
28 Jul, 09:35 — 28 Jul, 09:35
Sources
Showing 1 of 1 sources
Argenx has signed an agreement to acquire Forte Biosciences in a deal valued at $2.2 billion.
